Skip to main content
. 2007 Nov;14(11):751–766. doi: 10.1111/j.1365-2893.2007.00865.x

Table 3.

Annual drug acquisition costs (2005)

Drugs Annual acquisition costs (wholesale) of drugs ($S)
LAM 2774.00
ADF 3606.20
IFN* 7329.75
PEG-IFN 20 740.00

LAM, lamivudine; PEG-IFN, pegylated-interferon; ADF, adefovir.

*

IFN costs are the average for Roferon-A and Intron-A (range of doses) and 6–12 months treatment durations.

PEG-IFN costs are the average of those for Pegasys and Peg-Intron for a duration of 12 months.